On May 12, 2023, LaNova Medicines announced the signing of an exclusive licensing agreement with AstraZeneca for LM-305, a pre-clinical stage antibody-drug conjugate comprising an anti-GPRC5D monoclonal antibody, a degradable protease linker, and a cytotoxic payload of MMAE
The first skin whitening body scrub to provide you with unequaled skin whitening while getting rid of deep-seated dirt and dead skin cells, revealing a fresher, radiant complexion
Manole F, Marian P, Mekeres GM, Csep AN
(jofem.org) The best-case signal: modest weight loss in a shorter trial A frequently cited 12-week randomized trial result (as summarized in reviews) reported: ~2.6 kg average loss with AOD-9604 1 mg/day vs ~0.8 kg with placebo (PMC) This is the kind of result that can be statistically meaningful, clinically modest, and very sensitive to study design (diet, activity, baseline metabolic status, adherence)
Su eficacia est demostrada, con una prdida media del 21% del peso corporal en el estudio STEP-1
Which peptide is best for hair growth